Symbols / ACLX Stock $115.05 +0.04% Arcellx, Inc.

Healthcare • Biotechnology • United States • NMS
ACLX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company preclinical product includes ACLX-004 for the treatment of AML and MDS. Further, the company focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize nito-cel and next-generation autologous and non-autologous CAR-T cell therapy products. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Stock Fundamentals
Scroll to Statements
Market Cap 6.73B Enterprise Value 6.33B Income -228.93M Sales 22.29M Book/sh 6.95 Cash/sh 7.70
Dividend Yield — Payout 0.00% Employees 209 IPO — P/E — Forward P/E -66.42
PEG — P/S 301.90 P/B 16.56 P/C — EV/EBITDA -25.68 EV/Sales 283.89
Quick Ratio 4.32 Current Ratio 4.43 Debt/Eq 12.90 LT Debt/Eq — EPS (ttm) -4.07 EPS next Y -1.73
EPS Growth — Revenue Growth -89.20% Earnings 2026-05-07 ROA -24.05% ROE -53.42% ROIC —
Gross Margin 0.00% Oper. Margin -38.50% Profit Margin 0.00% Shs Outstand 58.48M Shs Float 42.25M Short Float 5.27%
Short Ratio 1.62 Short Interest — 52W High 115.13 52W Low 47.86 Beta 0.25 Avg Volume 2.17M
Volume 1.13M Target Price $112.85 Recom None Prev Close $115.00 Price $115.05 Change 0.04%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$112.85
Mean price target
2. Current target
$115.05
Latest analyst target
3. DCF / Fair value
$-29.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$115.05
Low
$82.00
High
$120.00
Mean
$112.85

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-26 down Guggenheim Buy → Neutral $115
2026-02-24 down Truist Securities Buy → Hold $120
2026-02-24 down Evercore ISI Group Outperform → In-Line $115
2026-02-24 down UBS Buy → Neutral $115
2026-02-24 down Citigroup Buy → Neutral $115
2026-02-24 down Leerink Partners Outperform → Market Perform $115
2026-02-24 down Stifel Buy → Hold $115
2026-02-23 down HC Wainwright & Co. Buy → Neutral $115
2026-02-23 down Baird Outperform → Neutral $115
2026-02-23 down Needham Buy → Hold —
2026-02-23 down Wells Fargo Overweight → Equal-Weight $115
2026-02-05 reit Needham Buy → Buy $105
2026-02-04 reit HC Wainwright & Co. Buy → Buy $115
2025-12-22 init Wells Fargo — → Overweight $100
2025-12-08 main Canaccord Genuity Buy → Buy $130
2025-12-08 reit Needham Buy → Buy $105
2025-11-18 init Wolfe Research — → Peer Perform —
2025-11-03 main Canaccord Genuity Buy → Buy $130
2025-07-31 main Scotiabank Sector Outperform → Sector Outperform $133
2025-06-17 init Citigroup — → Buy $110
News
RSS: Latest ACLX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-16 GILSON MICHELLE Chief Financial Officer — 38,110 $8.66 $330,033
2026-03-17 GILSON MICHELLE Chief Financial Officer — 5,000 $0.00 $0
2026-03-04 ELGHANDOUR RAMI Chief Executive Officer — 101,164 $0.00 $0
2026-02-27 ELGHANDOUR RAMI Chief Executive Officer — 89,916 $113.92 $10,243,267
2026-02-25 GILSON MICHELLE Chief Financial Officer — 11,219 $113.82 $1,276,954
2026-02-19 GILSON MICHELLE Chief Financial Officer — 8,384 $67.73 $572,568
2026-02-17 GILSON MICHELLE Chief Financial Officer — 11,291 $69.21 $784,783
2026-02-11 ELGHANDOUR RAMI Chief Executive Officer — 218,500 $0.00 $0
2026-02-11 ELGHANDOUR RAMI Chief Executive Officer — 198,000 $0.00 $0
2026-01-20 LUBNER DAVID CHARLES Director — 6,000 $75.00 $450,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
22.29
-79.35%
107.94
-2.16%
110.32
0.00
Operating Revenue
22.29
-79.35%
107.94
-2.16%
110.32
0.00
Operating Expense
275.37
+12.16%
245.51
+22.63%
200.20
+4.67%
191.26
Research And Development
157.61
+0.33%
157.09
+17.37%
133.85
-10.50%
149.56
Selling General And Administration
117.76
+33.19%
88.41
+33.25%
66.35
+59.10%
41.70
General And Administrative Expense
117.76
+33.19%
88.41
+33.25%
66.35
+59.10%
41.70
Other Gand A
117.76
+33.19%
88.41
+33.25%
66.35
+59.10%
41.70
Total Expenses
275.37
+12.16%
245.51
+22.63%
200.20
+4.67%
191.26
Operating Income
-253.08
-83.97%
-137.57
-53.06%
-89.88
+53.01%
-191.26
Total Operating Income As Reported
-253.08
-83.97%
-137.57
-53.06%
-89.88
+53.01%
-191.26
EBITDA
-222.19
-124.29%
-99.06
-54.43%
-64.14
+65.45%
-185.64
Normalized EBITDA
-222.19
-124.29%
-99.06
-54.43%
-64.14
+65.45%
-185.64
Reconciled Depreciation
6.68
+28.72%
5.19
+154.31%
2.04
+54.43%
1.32
EBIT
-228.87
-119.54%
-104.25
-57.51%
-66.19
+64.60%
-186.96
Net Income
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Pretax Income
-228.87
-117.39%
-105.28
-50.34%
-70.03
+62.89%
-188.68
Net Non Operating Interest Income Expense
24.22
-25.00%
32.29
+62.66%
19.85
+669.50%
2.58
Interest Expense Non Operating
0.00
-100.00%
1.03
-73.19%
3.84
+123.37%
1.72
Net Interest Income
24.22
-25.00%
32.29
+62.66%
19.85
+669.50%
2.58
Interest Expense
0.00
-100.00%
1.03
-73.19%
3.84
+123.37%
1.72
Interest Income Non Operating
24.22
-27.32%
33.32
+40.63%
23.70
+451.05%
4.30
Interest Income
24.22
-27.32%
33.32
+40.63%
23.70
+451.05%
4.30
Other Income Expense
—
—
—
—
Other Non Operating Income Expenses
—
—
—
—
Tax Provision
0.07
-96.67%
2.07
+212.07%
0.66
0.00
Tax Rate For Calcs
0.00
-100.00%
0.00
+0.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Net Income From Continuing Operation Net Minority Interest
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Net Income From Continuing And Discontinued Operation
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Net Income Continuous Operations
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Normalized Income
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Net Income Common Stockholders
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Diluted EPS
—
-2.00
-36.05%
-1.47
+71.68%
-5.19
Basic EPS
—
-2.00
-36.05%
-1.47
+71.68%
-5.19
Basic Average Shares
—
53.57
+11.45%
48.06
+32.20%
36.36
Diluted Average Shares
—
53.57
+11.45%
48.06
+32.20%
36.36
Diluted NI Availto Com Stockholders
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
603.99
-15.09%
711.33
-13.79%
825.13
+162.93%
313.82
Current Assets
462.18
-22.88%
599.31
-16.34%
716.36
+168.44%
266.86
Cash Cash Equivalents And Short Term Investments
450.33
-23.33%
587.38
-16.33%
702.02
+175.48%
254.84
Cash And Cash Equivalents
80.26
-24.05%
105.68
-73.22%
394.58
+514.82%
64.18
Other Short Term Investments
370.07
-23.17%
481.70
+56.68%
307.43
+61.25%
190.66
Prepaid Assets
4.03
-31.55%
5.88
-13.04%
6.76
-19.10%
8.36
Restricted Cash
0.00
-100.00%
0.21
-89.07%
1.90
0.00
Other Current Assets
7.82
+33.84%
5.84
+2.92%
5.68
+54.87%
3.67
Total Non Current Assets
141.81
+26.59%
112.02
+2.99%
108.77
+131.65%
46.95
Net PPE
66.47
-5.38%
70.25
+0.60%
69.83
+75.05%
39.89
Gross PPE
82.21
+3.17%
79.69
+6.14%
75.08
+73.19%
43.35
Accumulated Depreciation
-15.75
-66.74%
-9.44
-79.78%
-5.25
-51.78%
-3.46
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.21
+14.00%
1.06
+29.76%
0.82
+240.25%
0.24
Construction In Progress
0.00
-100.00%
0.20
-97.43%
7.79
+358.35%
1.70
Other Properties
42.63
+6.43%
40.05
+1.87%
39.31
+0.78%
39.01
Leases
38.37
+0.00%
38.37
+41.32%
27.15
+1031.85%
2.40
Investments And Advances
69.72
+82.14%
38.28
+40.89%
27.17
0.00
Non Current Deferred Assets
—
—
—
0.00
Other Non Current Assets
5.62
+60.92%
3.50
-70.32%
11.77
+66.68%
7.06
Total Liabilities Net Minority Interest
201.64
-21.40%
256.54
-24.49%
339.75
+212.09%
108.86
Current Liabilities
104.20
-16.91%
125.41
+6.06%
118.24
+108.56%
56.69
Payables And Accrued Expenses
21.73
-45.45%
39.84
+455.06%
7.18
-41.42%
12.25
Payables
11.13
-52.29%
23.34
+790.99%
2.62
-71.07%
9.05
Accounts Payable
5.58
+166.16%
2.10
-20.01%
2.62
-71.07%
9.05
Current Accrued Expenses
10.60
-35.79%
16.51
+262.08%
4.56
+42.42%
3.20
Pensionand Other Post Retirement Benefit Plans Current
14.56
+39.51%
10.44
+88.79%
5.53
+3.40%
5.35
Current Debt And Capital Lease Obligation
7.58
+0.56%
7.54
-83.89%
46.78
+30.10%
35.96
Current Capital Lease Obligation
7.58
+0.56%
7.54
-83.89%
46.78
+30.10%
35.96
Current Deferred Liabilities
55.97
-5.23%
59.06
+16.87%
50.53
0.00
Current Deferred Revenue
55.97
-5.23%
59.06
+16.87%
50.53
0.00
Other Current Liabilities
4.36
-48.89%
8.53
+3.86%
8.21
+162.34%
3.13
Total Non Current Liabilities Net Minority Interest
97.44
-25.69%
131.13
-40.80%
221.51
+324.60%
52.17
Long Term Debt And Capital Lease Obligation
44.34
-4.73%
46.54
-8.46%
50.84
-2.55%
52.17
Long Term Capital Lease Obligation
44.34
-4.73%
46.54
-8.46%
50.84
-2.55%
52.17
Non Current Deferred Liabilities
53.10
-30.13%
76.00
-55.47%
170.67
0.00
Non Current Deferred Revenue
53.10
-30.13%
76.00
-55.47%
170.67
0.00
Other Non Current Liabilities
—
8.59
—
—
Preferred Securities Outside Stock Equity
—
—
—
0.00
Stockholders Equity
402.35
-11.53%
454.79
-6.30%
485.38
+136.82%
204.95
Common Stock Equity
402.35
-11.53%
454.79
-6.30%
485.38
+136.82%
204.95
Capital Stock
0.06
+5.66%
0.05
+1.92%
0.05
+18.18%
0.04
Common Stock
0.06
+5.66%
0.05
+1.92%
0.05
+18.18%
0.04
Preferred Stock
—
—
—
0.00
Share Issued
57.93
+6.70%
54.29
+3.85%
52.28
+18.53%
44.11
Ordinary Shares Number
57.93
+6.70%
54.29
+3.85%
52.28
+18.53%
44.11
Additional Paid In Capital
1,127.21
+18.56%
950.72
+8.75%
874.26
+66.87%
523.92
Retained Earnings
-725.76
-46.08%
-496.83
-27.56%
-389.48
-22.17%
-318.79
Gains Losses Not Affecting Retained Earnings
0.84
-0.59%
0.85
+55.03%
0.55
+347.51%
-0.22
Other Equity Adjustments
0.84
-0.59%
0.85
+55.03%
0.55
+347.51%
-0.22
Total Equity Gross Minority Interest
402.35
-11.53%
454.79
-6.30%
485.38
+136.82%
204.95
Total Capitalization
402.35
-11.53%
454.79
-6.30%
485.38
+136.82%
204.95
Working Capital
357.98
-24.46%
473.90
-20.77%
598.12
+184.59%
210.17
Invested Capital
402.35
-11.53%
454.79
-6.30%
485.38
+136.82%
204.95
Total Debt
51.92
-4.00%
54.08
-44.60%
97.62
+10.77%
88.13
Capital Lease Obligations
51.92
-4.00%
54.08
-44.60%
97.62
+10.77%
88.13
Net Tangible Assets
402.35
-11.53%
454.79
-6.30%
485.38
+136.82%
204.95
Tangible Book Value
402.35
-11.53%
454.79
-6.30%
485.38
+136.82%
204.95
Available For Sale Securities
69.72
+82.14%
38.28
+40.89%
27.17
—
Dueto Related Parties Current
5.56
-73.83%
21.24
0.00
—
Investmentin Financial Assets
69.72
+82.14%
38.28
+40.89%
27.17
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-210.26
-151.91%
-83.47
-140.21%
207.57
+309.03%
-99.30
Cash Flow From Continuing Operating Activities
-210.26
-151.91%
-83.47
-140.21%
207.57
+309.03%
-99.30
Net Income From Continuing Operations
-228.93
-113.26%
-107.35
-51.86%
-70.69
+62.53%
-188.68
Depreciation Amortization Depletion
6.68
+28.72%
5.19
+154.31%
2.04
+54.43%
1.32
Depreciation And Amortization
6.68
+28.72%
5.19
+154.31%
2.04
+54.43%
1.32
Other Non Cash Items
-0.04
-100.93%
4.10
-79.36%
19.88
-69.02%
64.18
Stock Based Compensation
77.89
+27.51%
61.09
+46.18%
41.79
+93.97%
21.54
Operating Gains Losses
0.08
+131.54%
-0.26
-249.43%
0.17
+5700.00%
0.00
Gain Loss On Sale Of PPE
0.08
+131.54%
-0.26
-249.43%
0.17
+5700.00%
0.00
Change In Working Capital
-57.49
-86.80%
-30.78
-113.65%
225.43
+4963.50%
4.45
Change In Prepaid Assets
-2.21
-125.68%
8.61
+203.01%
-8.36
-46.78%
-5.70
Change In Payables And Accrued Expense
-18.77
-144.76%
41.94
+4860.39%
-0.88
-112.54%
7.02
Change In Accrued Expense
-21.44
-151.03%
42.01
+651.10%
5.59
+1515.95%
-0.40
Change In Payable
2.66
+3905.71%
-0.07
+98.92%
-6.47
-187.26%
7.42
Change In Account Payable
2.66
+3905.71%
-0.07
+98.92%
-6.47
-187.26%
7.42
Change In Other Working Capital
-25.99
+69.84%
-86.15
-138.95%
221.21
—
Change In Other Current Liabilities
-10.52
-318.07%
4.83
-64.15%
13.46
+331.03%
3.12
Investing Cash Flow
86.30
+147.15%
-183.04
-18.47%
-154.51
-31.31%
-117.67
Cash Flow From Continuing Investing Activities
86.30
+147.15%
-183.04
-18.47%
-154.51
-31.31%
-117.67
Net PPE Purchase And Sale
-2.33
+82.68%
-13.43
+37.31%
-21.43
-841.06%
-2.28
Purchase Of PPE
-2.33
+82.68%
-13.43
+37.31%
-21.43
-841.06%
-2.28
Capital Expenditure
-2.33
+82.68%
-13.43
+37.31%
-21.43
-841.06%
-2.28
Net Investment Purchase And Sale
88.62
+152.25%
-169.61
-27.45%
-133.08
-15.33%
-115.40
Purchase Of Investment
-406.98
+31.87%
-597.31
-35.01%
-442.43
-61.63%
-273.74
Sale Of Investment
495.60
+15.88%
427.70
+38.26%
309.35
+95.37%
158.34
Financing Cash Flow
98.53
+509.08%
-24.09
-108.63%
279.16
+10.50%
252.62
Cash Flow From Continuing Financing Activities
98.53
+509.08%
-24.09
-108.63%
279.16
+10.50%
252.62
Net Issuance Payments Of Debt
-0.23
+99.42%
-39.85
-35.57%
-29.39
-203.79%
-9.68
Repayment Of Debt
-0.23
+99.42%
-39.85
-35.57%
-29.39
-203.79%
-9.68
Long Term Debt Payments
-0.23
+99.42%
-39.85
-35.57%
-29.39
-203.79%
-9.68
Net Long Term Debt Issuance
-0.23
+99.42%
-39.85
-35.57%
-29.39
-203.79%
-9.68
Net Common Stock Issuance
131.56
0.00
-100.00%
299.71
+15.35%
259.83
Common Stock Payments
—
—
0.00
0.00
Repurchase Of Capital Stock
—
—
0.00
0.00
Proceeds From Stock Option Exercised
5.62
-64.31%
15.76
+78.09%
8.85
+258.69%
2.47
Net Other Financing Charges
-38.42
—
—
—
Changes In Cash
-25.43
+91.25%
-290.60
-187.47%
332.22
+831.96%
35.65
Beginning Cash Position
108.31
-72.85%
398.90
+498.24%
66.68
+114.87%
31.03
End Cash Position
82.88
-23.48%
108.31
-72.85%
398.90
+498.24%
66.68
Free Cash Flow
-212.59
-119.38%
-96.90
-152.06%
186.15
+283.25%
-101.58
Income Tax Paid Supplemental Data
1.32
-19.33%
1.64
+671.23%
0.21
0.00
Amortization Of Securities
-8.44
+45.38%
-15.46
-39.93%
-11.05
-419.91%
-2.12
Common Stock Issuance
131.56
0.00
-100.00%
299.71
+15.35%
259.83
Issuance Of Capital Stock
131.56
0.00
-100.00%
299.71
+15.35%
259.83
Net Preferred Stock Issuance
—
—
0.00
0.00
Preferred Stock Issuance
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category